Company requested Type B pre-IND meeting with U.S. FDA to discuss development and regulatory strategy for its investigational tetravalent T-cell engager, HCW11-018b. HCW11-018b ha ...

Researchers used germline variants to stratify therapy-related myeloid neoplasms (t-MNs) into molecularly and prognostically distinct subgroups beyond treatment-based classifications. They found that ...

First-of-Kind, Dual-CAR T cell Targeting CD19 and CD38 for Comprehensive Elimination of Complex, Multi-System Autoimmune Disorders Advances into Phase 1/2 Clinical Development Novel 13-point edited ...

Conventional TIL therapy, clinically validatedrecently with the U.S. Food and Drug Administration approval of lifileucel for advanced melanoma,stillfaces substantial hurdles. The standard expansion ...

Hiroshima University researchers have demonstrated a proof of concept for the mass production of genome-edited T cells that can be used to treat malignant tumors, using a genetic engineering technique ...

St. Louis' economic development agency wants to set the amount of public subsidies for a vacant, prominent lot at ...

Learn how to improve NGS library preparation, reduce bias, and increase sequencing yield with practical strategies for ...

This guide brings together practical recommendations and workflow considerations to reduce unnecessary troubleshooting and ...

Antibodies are pivotal in immunology, driving advancements in precision medicine with monoclonal antibodies, ADCs, and ...

With Miami's Mark Fletcher Jr., Duke's Nate Sheppard and Georgia Tech's Justice Haynes leading the way, the ACC's most loaded ...